The role of mast cells in common gastrointestinal diseases

被引:29
作者
Siddiqui, AA [1 ]
Miner, PB [1 ]
机构
[1] Oklahoma Fdn Digest Res, Oklahoma City, OK 73104 USA
关键词
D O I
10.1007/s11882-004-0043-z
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The gastrointestinal tract is a rich source of mast cells with an enormous surface area that permits a high degree of interaction between the mast cell and the intestinal contents. The active metabolic products of the mast cell influence gastrointestinal secretion, absorption, and motility through paracrine effects of local mast cell activation and also cause systemic effects through the release of cellular products into the bloodstream. Recent advances in our knowledge of the immune system and the recognition that the gastrointestinal immune function might be partially mediated through gastrointestinal mucosal mast cells has opened mast cell research to the field of gastroenterology. Local gastrointestinal proliferation of mast cells in response to recognized or obscure stimuli can alter gastrointestinal function and induce systemic symptoms. Symptoms can arise from the increased number of mast cells, overproduction of specific mast cell mediators, and hyperactivity of the enteric nervous system that induces mast cell activation. The diseases mentioned in this review represent a small proportion of areas where mast cell function might play an important role in the response to disease and generation of symptoms.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 52 条
  • [1] MAST-CELLS IN ULCERATIVE-COLITIS - QUANTITATIVE AND ULTRASTRUCTURAL STUDIES
    BALAZS, M
    ILLYES, G
    VADASZ, G
    [J]. VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1989, 57 (06) : 353 - 360
  • [2] Mast cells are an important cellular source of tumour necrosis factor α in human intestinal tissue
    Bischoff, SC
    Lorentz, A
    Schwengberg, S
    Weier, G
    Raab, R
    Manns, MP
    [J]. GUT, 1999, 44 (05) : 643 - 652
  • [3] Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls
    Bischoff, SC
    Schwengberg, S
    Wordelmann, K
    Weimann, A
    Raab, R
    Manns, MP
    [J]. GUT, 1996, 38 (01) : 104 - 114
  • [4] Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
    Bischoff, SC
    Wedemeyer, J
    Herrmann, A
    Meier, PN
    Trautwein, C
    Cetin, Y
    Maschek, H
    Stolte, M
    Gebel, M
    Manns, MP
    [J]. HISTOPATHOLOGY, 1996, 28 (01) : 1 - 13
  • [5] Bueno L., 1999, CAN J GASTROENTEROL, V13, p42A , DOI [DOI 10.1136/gutjnl-2014-307843, DOI 10.1155/1999/846809]
  • [6] Treatment of adult systemic mastocytosis with interferon-α:: results of a multicentre phase II trial on 20 patients
    Casassus, P
    Caillat-Vigneron, N
    Martin, A
    Simon, J
    Gallais, V
    Beaudry, P
    Eclache, V
    Laroche, L
    Lortholary, P
    Raphaël, M
    Guillevin, L
    Lortholary, O
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (04) : 1090 - 1097
  • [7] Mastocytosis: Mediator-related signs and symptoms
    Castells, M
    Austen, KF
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 127 (02) : 147 - 152
  • [8] CHAUDHARY NA, 1962, Q J MED, V31, P307
  • [9] GASTROINTESTINAL DYSFUNCTION IN SYSTEMIC MASTOCYTOSIS - A PROSPECTIVE-STUDY
    CHERNER, JA
    JENSEN, RT
    DUBOIS, A
    ODORISIO, TM
    GARDNER, JD
    METCALFE, DD
    [J]. GASTROENTEROLOGY, 1988, 95 (03) : 657 - 667
  • [10] CLOUSE RE, 1994, ALIMENT PHARM THERAP, V8, P409